This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB06980/identifier/pdb/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06980/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB06980/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB06980/identifier/drugbank/

Statements

Subject Item
n2:DB06980
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB06980 n13:DB06980
dcterms:title
(2S)-2-(1H-indol-3-yl)hexanoic acid
adms:identifier
n9:24768549 n10:99443451 n11:DB06980 n12:2S2
n3:IUPAC-Name
n4:271B64C8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B64CE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B64CD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B64CA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B64CB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B64CC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B64C6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B64C4-363D-11E5-9242-09173F13E4C5 n4:271B64C7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B64C5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B64D4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B64D5-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B64CF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B64D0-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B64D2-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B64D1-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B64D3-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B64D9-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B64DB-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B64DC-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B64D8-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B64D7-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B64DA-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B64C9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B64D6-363D-11E5-9242-09173F13E4C5